Injectable Drug Delivery Devices Market Insights: Revenue Expected to Surpass $73.85 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the injectable drug delivery devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Injectable Drug Delivery Devices Market?

The injectable drug delivery devices market has shown strong growth in recent years. It is projected to expand from $49.59 billion in 2024 to $54.3 billion in 2025, at a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to the rapid increase in the elderly population, a rise in the number of healthcare facilities, greater healthcare expenditure, the growth in biologics, and increasing awareness of self-administration.

The injectable drug delivery devices market is projected for significant expansion over the coming years, reaching $73.85 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. This projected growth is driven by factors such as the rising incidence of chronic diseases, a growing need for injectable medications, the abrupt appearance of severe infections, and a substantial pipeline of drugs and vaccines undergoing clinical trials. Key trends anticipated during this period involve an emphasis on creating microneedle-based systems for drug delivery, investment in the research and development of self-injectable devices, the production of wearable devices, and the development of needle-free injection systems. Additionally, companies are broadening their offerings to include prefilled syringes, enhancing the digital capabilities of their devices, and focusing on producing innovative devices, particularly auto-injectors.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

Which Growth Drivers Are Propelling The Injectable Drug Delivery Devices Market?

A growing inclination towards self-injection devices is propelling the injectable drug delivery devices market. These medical instruments, known as self-injection devices, allow patients to administer their own medication at home. Types of self-injection devices encompass needle-free, auto, pen, and wearable injectors. The development of these self-injectables aimed to offer highly adaptable devices that ensure precise drug delivery and user-friendliness. Furthermore, recent innovations in self-injectable devices have led to a rise in their adoption in recent years. An example is BD Physioject, a disposable auto-injector from Becton, Dickinson, and Company, which is clinically validated, dependable, and economical, specifically created for patients with chronic conditions such as rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis to self-inject medications. Other key players in the self-injections market comprise AbbVie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., among others. The benefits of self-injectable methods, coupled with growing awareness regarding self-administration, have boosted the demand for self-injectable devices and are expected to further propel the injectable drug delivery devices market throughout the forecast period.

Which Segmentation Factors Are Most Significant In The Injectable Drug Delivery Devices Market Analysis?

The injectable drug delivery devicesmarket covered in this report is segmented –

1) By Type: Syringes, Injectors And Pump

2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications

3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users

Subsegments:

1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes

2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors

3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps

What New Opportunities Are Emerging From Trends In The Injectable Drug Delivery Devices Market?

Companies involved in the production of injectable drug delivery devices are increasingly directing their attention towards manufacturing auto-injectors. These auto-injectors are completely automated, extensively customizable, and reusable, allowing patients to administer hundreds of injections. Individuals can manage the pace of dose delivery to help alleviate pain or discomfort during the injection. These devices possess the capability to modify both the speed and depth of the automatic injection. For example, LISA, a reusable auto-injector produced by Unilife corporation, incorporates numerous customizable attributes, including Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and drug warming prior to injection for targeted therapies. The injectable drug delivery technology market is anticipated to exhibit considerable expansion in the upcoming years, propelled by various technological improvements and new product releases designed to enhance the convenience and simplicity of administering parenteral therapeutics.

Who Are The Most Influential Companies In The Injectable Drug Delivery Devices Market?

Major companies operating in the injectable drug delivery devices market include Becton, Dickinson and Company, Baxter International, Gerresheimer AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Which Region Holds The Largest Share In The Injectable Drug Delivery Devices Market Today?

North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2835&type=smp

Browse Through More Reports Similar to the Global Injectable Drug Delivery Devices Market 2025, By The Business Research Company

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Liposomal Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795